methamphetamine has been researched along with cannabidiol in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 16 (76.19) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Haghparast, A; Karimi-Haghighi, S | 1 |
| Cosenza, A; Di Gaudio, F; Fanara, S; Maida, CM; Piscionieri, D; Viviani, G | 1 |
| Arnold, JC; Baracz, SJ; Cornish, JL; Costa, PA; Everett, NA; Hay, GL; McGregor, IS; Roberts, J | 1 |
| Dargahi, L; Haghparast, A; Karimi-Haghighi, S | 1 |
| Aguilar, MA; Calpe-López, C; García-Pardo, MP | 1 |
| Haghparast, A; Mehdizadeh, M; Razavi, Y; Shabani, R | 1 |
| Galaj, E; Xi, ZX | 1 |
| Anooshe, M; Haghparast, A; Karimi-Haghighi, S; Mousavi, Z; Nouri, K | 2 |
| Haghparast, A; Khanegheini, A; Khani, M; Taleghani, BK; Yousefzadeh-Chabok, S; Zarrabian, S | 1 |
| Haghparast, A; Hassanlou, AA; Jamali, S; Mousavi, Z; RayatSanati, K | 1 |
| Haghparast, A; Keyhanfar, F; Mehdizadeh, M; Razavi, Y; Shabani, R | 1 |
| Ahadi, R; Asgari, HR; Haghparast, A; Karimi-Haghighi, S; Shabani, R; Sharifi, A | 1 |
| Guan, L; Hong, S; Huang, J; Li, L; Li, Y; Liu, L; Shen, B; Yang, G; Zeng, X; Zhang, D | 1 |
| Arnold, JC; Baracz, SJ; Cornish, JL; Costa, PA; Everett, NA; McGregor, IS; Michelutti, EA; Sauer, M; Turner, AJ; Umpierrez, LS | 1 |
| Benyamina, A; Billieux, J; Karila, L; Paulus, V | 1 |
| Pastor, V | 1 |
| Leung, CK; Li, J; Li, M; Lin, S; Liu, J; Liu, L; Tan, Y; Wang, C; Wang, H; Xu, Y; Yang, G; Zeng, X; Zhang, H; Zhang, S | 1 |
| Cheaha, D; Kumarnsit, E; Nukitram, J | 1 |
| Azizbeigi, R; Eskandari, K; Haghparast, A; Mohammadi, M | 1 |
3 review(s) available for methamphetamine and cannabidiol
| Article | Year |
|---|---|
Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms.
Topics: Amphetamine-Related Disorders; Animals; Cannabidiol; Cocaine-Related Disorders; Health Risk Behaviors; Humans; Methamphetamine; Mice; Observational Studies as Topic; Resilience, Psychological; Substance Withdrawal Syndrome | 2019 |
Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals.
Topics: Animals; Behavior, Animal; Brain; Cannabidiol; Cannabinoids; Disease Models, Animal; Dopamine; Humans; Methamphetamine; Piperidines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptor, Serotonin, 5-HT1A; Recurrence; Reward; Self Administration; Substance-Related Disorders; TRPV Cation Channels | 2020 |
Cannabidiol in the context of substance use disorder treatment: A systematic review.
Topics: Animals; Cannabidiol; Cannabis; Cocaine; Humans; Methamphetamine; Nicotine; Substance-Related Disorders | 2022 |
18 other study(ies) available for methamphetamine and cannabidiol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats.
Topics: Amphetamine-Related Disorders; Animals; Cannabidiol; Central Nervous System Agents; Conditioning, Psychological; Dose-Response Relationship, Drug; Male; Methamphetamine; Motivation; Random Allocation; Rats, Wistar; Sleep Deprivation; Spatial Behavior | 2018 |
Occurrence of illicit drugs in two wastewater treatment plants in the South of Italy.
Topics: Amphetamine; Amphetamines; Cannabidiol; Cocaine; Dronabinol; Drug Combinations; Humans; Illicit Drugs; Methamphetamine; Pyrrolidines; Sicily; Substance Abuse Detection; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2018 |
Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats.
Topics: Amphetamine-Related Disorders; Animals; Cannabidiol; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; Motivation; Rats; Rats, Sprague-Dawley; Recurrence; Reinforcement Schedule; Self Administration | 2018 |
Cannabidiol modulates the expression of neuroinflammatory factors in stress- and drug-induced reinstatement of methamphetamine in extinguished rats.
Topics: Amphetamine-Related Disorders; Animals; Anticonvulsants; Brain; Cannabidiol; Central Nervous System Stimulants; Disease Models, Animal; Inflammation; Male; Methamphetamine; Rats; Rats, Wistar; Stress, Physiological | 2020 |
Neuroprotective effect of chronic administration of cannabidiol during the abstinence period on methamphetamine-induced impairment of recognition memory in the rats.
Topics: Animals; Cannabidiol; Infusions, Intraventricular; Male; Maze Learning; Memory Disorders; Methamphetamine; Neuroprotective Agents; Rats; Recognition, Psychology | 2020 |
Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat.
Topics: Animals; Cannabidiol; Conditioning, Classical; Dose-Response Relationship, Drug; Locomotion; Male; Methamphetamine; Rats; Rats, Wistar; Reward | 2021 |
Cannabidiol enhanced the development of sensitization to the expression of methamphetamine-induced conditioned place preference in male rats.
Topics: Animals; Cannabidiol; Central Nervous System Stimulants; Conditioning, Classical; Male; Methamphetamine; Rats; Reward | 2021 |
Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region.
Topics: Animals; CA1 Region, Hippocampal; Cannabidiol; Central Nervous System Stimulants; Conditioning, Operant; Dopamine Antagonists; Male; Methamphetamine; Rats; Rats, Wistar; Receptors, Dopamine D2; Sulpiride | 2021 |
Involvement of Hippocampal D1-Like Dopamine Receptors in the Inhibitory Effect of Cannabidiol on Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference.
Topics: Animals; Benzazepines; CA1 Region, Hippocampal; Cannabidiol; Central Nervous System Agents; Conditioning, Psychological; Dopamine Antagonists; Male; Methamphetamine; Rats, Wistar; Receptors, Dopamine D1 | 2021 |
Cannabidiol promotes neurogenesis in the dentate gyrus during an abstinence period in rats following chronic exposure to methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Cannabidiol; Cell Proliferation; Central Nervous System Stimulants; Chronic Disease; Dentate Gyrus; Hippocampus; Injections, Intraventricular; Male; Methamphetamine; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2021 |
Cannabidiol impairs the rewarding effects of methamphetamine: Involvement of dopaminergic receptors in the nucleus accumbens.
Topics: Animals; Benzazepines; Cannabidiol; Conditioning, Classical; Dopamine Antagonists; Male; Methamphetamine; Nucleus Accumbens; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward; Sulpiride; Ventral Tegmental Area | 2022 |
Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cannabidiol; Dopamine; Methamphetamine; Methyl-CpG-Binding Protein 2; Rats; Receptor, trkB; Receptors, Dopamine D1; Signal Transduction | 2022 |
Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses.
Topics: Animals; Antipsychotic Agents; Cannabidiol; Cannabinoids; Male; Methamphetamine; Rats; Rats, Sprague-Dawley | 2022 |
Cannabidiol as a pharmacotherapy tool for attenuating methamphetamine effects.
Topics: Amphetamine-Related Disorders; Cannabidiol; Humans; Methamphetamine | 2022 |
Cannabidiol attenuates methamphetamine-induced conditioned place preference in male rats and viability in PC12 cells through the Sigma1R/AKT/GSK3β/CREB signaling pathway.
Topics: Animals; Cannabidiol; Glycogen Synthase Kinase 3 beta; Male; Methamphetamine; PC12 Cells; Proto-Oncogene Proteins c-akt; Rats; RNA, Small Interfering; Signal Transduction | 2022 |
A 1:1 ratio of cannabidiol: tetrahydrocannabinol attenuates methamphetamine conditioned place preference in mice: A prospective study of antidopaminergic mechanism.
Topics: Animals; Bupropion; Cannabidiol; Central Nervous System Stimulants; Dronabinol; Male; Methamphetamine; Mice; Mice, Inbred ICR; Nucleus Accumbens; Prospective Studies | 2023 |
The inhibitory effect of cannabidiol on the rewarding properties of methamphetamine in part mediates by interacting with the hippocampal D1-like dopamine receptors.
Topics: Animals; Cannabidiol; Hippocampus; Methamphetamine; Rats; Rats, Wistar; Receptors, Dopamine D1; Reward | 2023 |